Joint Venture Between Sanofi Pasteur, Thailand's Government Pharmaceutical Organization (GPO) Aims for New Vaccine With Fewer Side Effects

Published: Nov 04, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A joint venture between Thailand's Government Pharmaceutical Organization (GPO) and France's Sanofi Pasteur is embarking upon a 700-million-baht upgrade to its vaccine production facility here. The expansion at Government Pharmaceutical Organization-Merieux Biological Products Co (GPO-MBP), to begin this year, will take eight years and result in a new combination vaccine with fewer side effects.

Help employers find you! Check out all the jobs and post your resume.

Back to news